Based on the reported correlation between expression of the IFN metagene and T‐cell metagene [5], as well as the lack of enrichment for immune genes in the ECM3+ subgroup of BC patients [4], we investigated the immune TME by considering the ECM3 and IFN markers jointly. Here, IFNA1 is linked to breast cancer.